Displaying items by tag:

The University of Alabama at Birmingham, Department of Nutrition Sciences, is conducting a research study to evaluate the effectiveness of an investigational drug to treat people with Type 2 Diabetes and obesity. To qualify, you must have Type 2 Diabetes, older than 18 years old, moderately overweight, diet-controlled or taking oral diabetes medications. Qualified participants will receive the study drug free of charge and compensation for time and travel. For more information, and to see if you might be eligible to join, please contact (205) 996-4015 or email at ccnrn@uab.edu.
The University of Alabama at Birmingham, Department of Nutrition Sciences, is conducting a 78-week research study to evaluate the effectiveness of an investigational drug to treat diabetes. In this trial, you will receive either once-weekly Icodec injections or once daily Lantus injections. To qualify, you must be 18 years old or older and have type 2 diabetes. Qualified participants will receive study drug, EKGs, eye exams, and Physical Exams. There is no charge for participation. Compensation for time and travel may also be available. For more information, and to see if you might be eligible to join, please call (205) 975-8217 or email mcr90@uab.edu.
You may qualify to participate in an international research study to evaluate the safety and tolerability of an investigational drug for patients with type 2 diabetes and kidney disease. Are you at least 18 years old? Do you have type 2 diabetes mellitus and a clinical diagnosis of kidney disease? Eligible study participants will receive study medications, blood pressure checks, physical exams, laboratory tests and ECG at no cost. Participants will  be reimbursed for time and travel. For more information, call the UAB Hypertension Program at 934-9281 or e-mail ccc-hlnresearch@mail.ad.uab.edu.